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WHO’S GUARDING THE HENHOUSE AND WHAT ARE THEY DOING 
WITH THE EGGS (AND SPERM)? 
A CALL FOR INCREASED REGULATION OF GAMETE DONATION AND 
LONG-TERM TRACKING OF DONOR GAMETES 
INTRODUCTION 
A man is born a red and wrinkled lump of flesh having no will of its own at 
all, absolutely at the mercy of the parents by whose conspiracy he has been 
brought into existence.  That is what no science of human community . . . 
must ever forget.1 
R. G. Collingwood 
Carolyn George wanted to expand her family.2  Being a single mother, 
she opted to conceive a child through insemination with donor sperm.3  In 
selecting a donor, she valued a clean bill of health as well as physical 
characteristics similar to those of her son from a previous relationship.4  
Ideally, Carolyn aspired to have a healthy child that looked like a member 
of her family down to the blond hair and green eyes.5 
Much to Carolyn’s surprise and dismay, soon after his birth her donor-
conceived son, Ethan, began to exhibit increasingly alarming symptoms 
including eczema, bloody and oozing skin, asthma, a severe egg allergy, 
and extensive bruising all over his body.6  After undergoing a battery of 
tests, he was diagnosed with a “rare genetic platelet disorder that causes 
bruises and bleeding from the slightest bump or cut.”7  Although Ethan’s 
diagnosis was not life-threatening and would not shorten his life span, it 
would last a lifetime.8  Because of this disorder, Ethan would have to avoid 
participation in normal childhood activities and interactions, such as sports 
or rough play that “might cause a blow to the head, leading to a brain 
bleed” which could result in a potentially life-threatening event.9 
 
 1. R. G. COLLINGWOOD, THE NEW LEVIATHAN OR MAN, SOCIETY, CIVILIZATION & BARBARISM 
176 (Oxford Univ. Press rev. ed. 1999). 
 2. Jennifer Wolff, The Truth About Donor 1084, SELF, Oct. 2006, at 203, 203. 
 3. Id. 
 4. Id. 
 5. Id. 
 6. Id. 
 7. Wolff, supra note 2, at 203. 
 8. Id. 
 9. Id. 
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Since Carolyn had no history of the disorder in her family, she was 
alarmed by the discovery.10  Therefore, she contacted the sperm bank to 
warn them of the possibility that Ethan’s donor, Donor 1084, carried the 
genetically-linked disorder.11  Despite her warning, the clinic continued to 
distribute Donor 1084’s sperm for use in insemination and, as a result, at 
least three other chronically ill children were conceived.12  In addition, when 
contacted nearly two years following Carolyn’s initial warning, the sperm 
bank denied any reports of adverse health conditions in Donor 1084’s 
offspring.13 
Unfortunately, Carolyn’s story is not unique.  Five out of eleven children 
conceived with Donor F827’s sperm from International Cryogenics 
contracted severe neutropenia, a hereditary disorder that causes bone 
marrow failure leading to frequent infections and a high incidence of 
leukemia.14  Donor 276 from California Cryobank was a carrier for a 
kidney disorder that ultimately requires kidney transplantation; 1500 vials of 
his sperm were sold to an “unknown number of women.”15  Across the 
country at Fairfax Cryobank in Virginia, Donor 2148’s donation resulted in 
one child afflicted with a latent genetic immune disorder and at least twenty-
two other known offspring who may or may not become infected in the 
future.16 
Since much of the assisted reproductive technology (“ART”) industry is 
self-regulated, little protection is available to donor offspring.17  In addition 
 
 10. Id. at 203-04. 
 11. Id. 
 12. Wolff, supra note 2, at 204. 
 13. Id. 
 14. Id.  See also Laurence A. Boxer & Steven Stein et al., Strong Evidence for Autosomal 
Dominant Inheritance of Severe Congenital Neutropenia Associated with ELA2 Mutations, 148 
J. PEDIATRICS 633, 633 (2006).  Through DNA testing of the affected children and their 
mothers, researchers determined that the sperm donor was a carrier of the disorder and did 
indeed pass it on to the donor-conceived children.  Id.; Nat’l Cancer Inst., Inherited Bone 
Marrow Failure Syndromes, http://marrowfailure.cancer.gov/SCN.html (last visited June 29, 
2010). 
 15. Steven Kotler, The God of Sperm: How a Powerful L.A. Sperm Peddler Shapes the 
Nation’s Rules on Disease, Genetics—and Accidental Incest, L.A. WEEKLY, Sept. 28-Oct. 4, 
2007, at 40, 42. 
 16. Id. 
 17. See Lars Noah, Assisted Reproductive Technologies and the Pitfalls of Unregulated 
Biomedical Innovation, 55 FLA. L. REV. 603, 614-16 (2003) (discussing the minimal amount of 
federal and state regulation of the ART industry, particularly for reporting adverse events); 
Judith F. Daar, Regulating Reproductive Technologies: Panacea or Paper Tiger?, 34 HOUS. L. 
REV. 609, 639 (1997) (stating that “practitioners in our country enjoy a nearly regulatory-free 
environment”).  See also generally Lori B. Andrews & Nanette Elster, Regulating Reproductive 
Technologies, 21 J. LEGAL MED. 35, 35-44 (2000) (outlining the history of federal and state 
regulation of ART). 
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to unknown health problems that may plague them, there is growing 
concern that they may inadvertently develop romantic relationships with half-
siblings that result in “accidental incest.”18  Without a centralized tracking 
system, no accurate data is available indicating just how many offspring any 
particular donor has or where they are located geographically.19  If a high 
number of half-siblings were to live in close proximity to one another, there 
is a possibility that two could meet and become romantically involved.  Any 
children resulting from such a relationship would have a much greater 
chance of inheriting a genetic disorder than those from unrelated parents.20 
Therefore, to ensure physical health and healthy relationships for donor 
offspring this paper calls for increased regulation of the ART industry.  Part I 
provides a history of donor-assisted reproduction and how it developed into 
the profitable industry it is today.  Part II outlines current federal, state, and 
private regulation of the industry.  Part III argues for reform to minimize the 
health concerns related to the use of donor gametes.  Finally, Part IV 
proposes regulations that support access to genetic and health information 
with the goal of increasing the safety of donor assisted reproduction while 
maintaining donor anonymity. 
I.  BACKGROUND 
“Donors of the Month Club.  It’s fun.  It’s fast.  It’s free.  Meet this month’s 
featured donors and check out their baby photos, snapshot bios, and 
interesting fun facts.”21 
“Genius Asian Egg Donor Needed—$35,000 Compensation.”22 
“Seeking Sperm Donor . . . It has always been my dream to have children.  
Please help me make . . . my dream come true!”23 
 
 18. See Kotler, supra note 15, at 41 (discussing fears that the lack of industry regulation 
will inevitably result in half-siblings unknowingly meeting and reproducing); see also Naomi 
Cahn, Accidental Incest:  Drawing the Line—or the Curtain?—for Reproductive Technology, 
32 HARV. J.L. & GENDER 59, 65 (2009) (arguing for “limits on the number of offspring born 
from any one individual’s gametes” due to the increased concern of incest among donor-
conceived children). 
 19. See Kotler, supra note 15, at 41 (discussing the lack of governance in the sperm bank 
industry and how it has been, and remains, a self-policed industry). 
 20. FRIEDRICH VOGEL & ARNO G. MOTULSKY, HUMAN GENETICS:  PROBLEMS AND 
APPROACHES 566 (3d ed. 1996). 
 21. Cal. Cryobank, Inc., Reproductive Services, http://www.cryobank.com/Donor-of-the-
Month/2010/February/ (last visited June 30, 2010) (describing a promotion touted in the 
rolling headlines on the main page of the website.  The website also states that February’s 
Donor of the Month features donors who “look like certain ‘people’ listed in one popular 
magazine’s 2009 Sexiest Men Alive issue.  Enjoy!”). 
 22. Genius Asian Egg Donor Needed—$35,000 Compensation, http://www.eggdonor 
needed.com/ (last visited June 30, 2010) (potential parents seeking egg donor with the goal 
of having a child capable of attending MIT, Caltech, or other top “world-class university”). 
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“Texas sperm donor and gentleman . . . Two successes in the past and 
working on a few more this month.”24 
More and more women are waiting until after thirty to start a family.25  It 
is estimated that twenty percent of American women now have their first 
child after the age of thirty-five.26  This delay may be due to various factors 
including increased availability of contraception, early focus on career, 
marrying at an older age, high divorce rate, delaying children until 
financially secure, or ignorance of decreasing fertility with advancing age.27 
As the number of “older” women who are trying to conceive grows, so 
does the incidence of age-related infertility.28  Approximately ten percent of 
the general population is affected by infertility.29  That percentage increases 
with the age of the potential parents.30  While a woman in her early twenties 
has only a six percent chance of remaining childless in her lifetime, a 
woman in her early forties has a sixty-four percent chance of never having 
children.31  In addition, a thirty-year-old woman has a twenty percent 
chance of getting pregnant each month while a forty-year-old only has 
about a five percent chance.32 
Although the use of third party reproduction to facilitate pregnancy has 
been practiced for over a century,33 current advances in reproductive 
 
 23. Seeking Sperm Donor, http://www.seekingspermdonor.com/ (last visited June 30, 
2010). 
 24. Yahoo Health Groups, Sperm_Donors_for_Committed_Couples-Individual_Co 
parenting, http://health.groups.yahoo.com/group/Sperm_Donors_for_Committed_Couples-
Individual_Coparenting/message/356 (last visited June 30, 2010) (website message board 
which connects sperm donors with those seeking their services). 
 25. See OFFICE ON WOMEN’S HEALTH, U.S. DEP’T OF HEALTH & HUMAN SERVS., INFERTILITY: 
FREQUENTLY ASKED QUESTIONS, at 2 [hereinafter WOMEN’S HEALTH FAQ], available at 
http://www.womenshealth.gov/faq/infertility.pdf. 
 26. Id. 
 27. AM. SOC’Y FOR REPRODUCTIVE MED., AGE AND FERTILITY: A GUIDE FOR PATIENTS 1, 3 
(2003) [hereinafter AGE AND FERTILITY], available at http://www.asrm.org (search “age and 
fertility” in search box). 
 28. WOMEN’S HEALTH FAQ, supra note 25, at 2. 
 29. RESOLVE: The Nat’l Infertility Ass’n, What Is Infertility?, http://www.resolve.org/ 
infertility-overview/what-is-infertility/ (last visited June 30, 2010) (RESOLVE is a national 
organization that provides education, support, and resources for those dealing with infertility.). 
 30. Nat’l Inst. of Health, Medline Plus, Infertility, http://www.nlm.nih.gov/medlineplus/ 
infertility.html (last visited June 30, 2010); AGE AND FERTILITY, supra note 27, at 3. 
 31. AGE AND FERTILITY, supra note 27, at 3. 
 32. Id. 
 33. See AM. SOC’Y FOR REPRODUCTIVE MED., THIRD PARTY REPRODUCTION: A GUIDE FOR 
PATIENTS 3, 9 (2006) [hereinafter THIRD PARTY REPRODUCTION], available at http://www.as 
rm.org/uploadedFiles/ASRM_Content/Resources/Patient_Resources/Fact_Sheets_and_Info_Bo
oklets/thirdparty.pdf . “‘Third party reproduction’ refers to the use of eggs, sperm, or embryos 
that have been donated by a third person (donor) to enable an infertile individual or couple 
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technology provide individuals and couples more options than ever before 
for creating a family.34  Patients undergoing chemotherapy can freeze their 
eggs or sperm for later use;35 lesbian couples can experience pregnancy 
and childbirth through sperm donation;36 and women with nonfunctioning 
ovaries can achieve fertility through ovary transplantation.37 
As the market for ART has increased and more reproductive options 
have become available, many individuals and couples are taking control of 
family planning.  For single women who hear the ticking of their biological 
clocks, carriers fearful of passing genetic disease onto their offspring, or 
couples facing infertility, one viable reproductive option is the use of “third 
party donors.”38  “Third party donors” provide their own sperm, eggs, or 
embryos (“gametes”) to a clinic or directly to a recipient for reproduction 
purposes.39  Depending on the process used to procure the donated 
gamete, the recipient may or may not know the identity of the donor.40 
While the word “donor” has traditionally been used to describe those 
who give freely and altruistically without any expectation of compensation, in 
the context of ART a “donor” may receive reasonable compensation for the 
service of providing his or her gametes.41  As there is no set standard for 
reasonable compensation in the industry, reimbursement for gamete 
donation varies between clinics.  One sperm bank advertises on its website 
that sperm donors can earn over $1000 per month;42 another reimburses 
up to $1200 per month with occasional incentives such as movie tickets or 
gift certificates rewarded to those who expend “extra time or effort.”43  In 
 
. . . to become parents.  Donors may be known or anonymous to the intended recipient.” Id. 
at 3. 
 34. See generally id. 
 35. Id. at 4, 9. 
 36. See id. at 9; BioCentre, Egg & Sperm Donation, http://www.bioethics.ac.uk/index. 
php?do=topic&sid=2 (last visited June 30, 2010) (defining egg and sperm donation and 
explaining their history and current use). 
 37. Mark Henderson, British Woman Has World’s First Baby by Full Ovary Transplant, 
TIMES ONLINE, Nov. 11, 2008, http://www.timesonline.co.uk/tol/life_and_style/health/article 
5133467.ece (last visited June 30, 2010). 
 38. See THIRD PARTY REPRODUCTION, supra note 33, at 3. 
 39. Id. 
 40. Id. 
 41. Ken Daniels, Donor Gametes: Anonymous or Identified?, 21 BEST PRAC. & RES. 
CLINICAL OBSTETRICS & GYNAECOLOGY 113, 114 (2007) [hereinafter Donor Gametes], 
available at http://www.donorsiblingregistry.com/kendaniels.pdf. 
 42. Northwest Andrology & Cryobank, Be a Sperm Donor, http://nwcryobank.com/118, 
spermdonorinformation (last visited Sept. 23, 2010) (In addition, donors can earn an extra 
$250 for referrals, if they become qualified sperm donors.). 
 43. California Cryobank, Inc., California Cyrobank Sperm Donor Compensation, 
https://www.spermbank.com/cd_secure/newdonors/index.cfm?ID=4 (last visited July 31, 
2010).  Although the California Cryobank’s website emphasizes that donors will help “others 
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general, men make between fifty and seventy-five dollars per donation.44  
Donations are usually provided on a weekly basis for up to a year.45  
Therefore, in a single year, a sperm donor can make between $2600 and 
$3900.  In contrast, egg donors are reimbursed between $5000 and 
$10,000 or more per donor cycle.46  Generally, egg donors can participate 
in two to three donor cycles per year.47 
Since compensation is involved, one may wonder if the motivation of the 
gamete donor is altruistic or self-serving.48  For young sperm donors 
(between the ages of eighteen and twenty-five), financial compensation 
generally serves as a primary motivator.49  In one survey of sperm donors, 
eighty-two percent listed financial reasons as a motivation for donating.50  In 
another, sixty-nine percent reported that they would cease donating if they 
stopped getting paid for it.51  In addition, many would not donate absent the 
guarantee of anonymity.52  In contrast, “older men [who] are more likely to 
know of people who have experienced infertility” do not consider money an 
important factor in the decision to donate.53  Their desire to help others is 
frequently cited as a motive for donating gametes.54 
Unlike sperm donation, which poses no physical risk to the donor, egg 
donation is generally an uncomfortable and time-consuming process 
requiring three months of hormone injections and ultimately egg retrieval 
 
in fulfilling their dreams,” the front cover of its donor brochure prominently displays a dollar 
sign outlined in sperm.  California Cryobank, Inc., Why Do I Want to Become a Sperm 
Donor?, https://www.spermbank.com/cd_secure/newdonors/index.cfm?ID=2 (last visited July 
31, 2010). 
 44. Letisia Marquez, UCLA Study Looks at Sperm Donation, UC NEWSROOM (May 23, 
2007), http://www.universityofcalifornia.edu/news/article/9238. 
 45. Id. 
 46. ConceiveAbilities, Egg Donor Compensation, http://www.conceiveabilities.com/ 
donor_pg_4a.htm (last visited July 31, 2010). 
 47. See ConceiveAbilities, Frequently Asked Questions, http://www.conceiveabilities.com/ 
donor_pg_6.htm (last visited July 31, 2010); Marquez, supra note 44. 
 48. See Donor Gametes, supra note 41, at 119. 
 49. BioCentre, supra note 36. 
 50. Ken R. Daniels, Ruth Curson & Gillian M. Lewis, Semen Donor Recruitment: A Study 
of Donors in Two Clinics, 11 HUM. REPROD. 746, 748 (1996) [hereinafter Semen Donor 
Recruitment]. 
 51. Mark V.Sauer et al., Attitudinal Survey of Sperm Donors to an Artificial Insemination 
Clinic, 34 J. REPROD. MED. 362, 362-63 (1989). 
 52. Rachel Cook & Susan Golombok, A Survey of Semen Donation: Phase II—the View of 
the Donors, 10 HUM. REPROD. 951, 954 (1995). 
 53. K. Daniels et al., Sperm Donation: Implications of Canada’s Assisted Human 
Reproduction Act 2004 for Recipients, Donors, Health Professionals, and Institutions, 28 J. 
OBSTETRICS & GYNAECOLOGY CANADA 608, 610 (2006) [hereinafter Sperm Donation]. 
 54. Id. 
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under local anesthesia.55  In addition to the discomfort of the injections and 
procedure itself, side effects for the donor may include abdominal swelling, 
tension and pressure in the ovarian area, mood swings, bruising at injection 
sites, or hot flashes.56  A less common risk is ovarian hyperstimulation 
syndrome (“OHSS”), “a serious complication marked by chest and 
abdominal fluid buildup and cystic enlargement of the ovaries that can 
cause permanent injury and even death.”57 
Due to the increased time commitment and complications of egg 
donation, potential donors whose primary motivation is monetary 
compensation may be deterred from the process.  As such, many egg 
donors have the more altruistic motive of helping an infertile couple 
conceive a child.58  Other potential donors include women who have 
excess, unused eggs remaining from their own infertility treatments.59  They 
may receive compensation in the form of a discount at their infertility clinic 
or may simply donate the unused eggs for no compensation whatsoever.60 
To receive donor gametes, recipients have the option of using agencies 
or clinics, close friends or relatives, or complete strangers located through 
advertisements in publications or online.61  Recipients seeking sperm, egg, 
and embryo donors through clinics often have access to the donor’s health 
history, medical and psychological profile, in addition to non-identifying 
biographical information.62  Alternatively, those who use non-traditional 
means to find a donor are on their own to discover such information. 
While minimally regulated, obtaining donor gametes through traditional 
clinics and banks requires some protocol; on the other hand, “buying sperm 
over the Internet . . . is not much different from buying shoes.”63 
 
 55. Michelle Sargent, Regulating Egg Donation: A Comparative Analysis of Reproductive 
Technologies in the United States and United Kingdom, 4 MICH. J. PUB. AFF. 1, 3, 11 (2007), 
available at http://www.mjpa.umich.edu/uploads/2/9/3/2/2932559/sargent-eggdonation-
final07.pdf. 
 56. Stanford University, Egg Donor Information Project: The Medical Procedure of Egg 
Donation, http://www.stanford.edu/class/siw198q/websites/eggdonor/procedures.html (last 
visited July 31, 2010). 
 57. Id.  Center for Genetics & Society, UK Woman Killed by Rare IVF Risk, Ovarian 
Hyperstimulation Syndrome, Apr. 13, 2005, http://www.geneticsandsociety.org/article.php?id 
=1625 (reporting that a thirty-three-year-old woman collapsed and later died of a heart 
attack after contracting OHSS from fertility treatment). 
 58. BioCentre, supra note 36. 
 59. THIRD PARTY REPRODUCTION, supra note 33, at 5, 12. 
 60. Id. at 5. 
 61. Id. at 4-5. 
 62. Id. at 5, 10. 
 63. Id. at 5; Jennifer Egan, Wanted: A Few Good Sperm, N.Y. TIMES, Mar. 19, 2006, at 
46. 
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Donor gametes may be obtained from anonymous donors through use 
of an agency or program or known donors through a personal 
acquaintance, advertisements, or an intermediary agency.64  “Today, sperm 
banking is a business with ‘customers’ instead of ‘patients,’ marketing plans 
instead of doctor’s orders, professional donors instead of Johnny-on-the-
spot medical students.”65  In fact, donors are often heavily marketed to 
couples through company websites.66  In addition to basic characteristics 
such as eye and hair color, height, and education level, couples may opt to 
learn of the donor’s hobbies, hear an audio tape of the donor’s voice, or 
even review the donor’s handwriting analysis (all for an extra fee, of 
course).67 
A. A Brief History 
The first reported case of donor insemination occurred in 1884 when a 
married couple that had been unable to conceive due to sterility of the 
husband consulted Dr. William Pancoast, a physician and medical school 
professor.68  In a procedure that denied the patient couple any ability to 
consent, Dr. Pancoast anesthetized the wife and inseminated her without 
either spouse’s knowledge.69  Since the husband’s semen could not be 
used, the doctor selected the sperm of the “best looking member of the 
class.”70  The procedure resulted in a successful pregnancy and subsequent 
birth.71  Although the husband was eventually informed of the procedure, 
 
 64. THIRD PARTY REPRODUCTION, supra note 33, at 4. 
 65. DAVID PLOTZ, THE GENIUS FACTORY: THE CURIOUS HISTORY OF THE NOBEL PRIZE SPERM 
BANK 159 (2005). 
 66. California Cryobank, Inc., Donor Recruitment: Where Does CCB Find All These 
Great Donors?, http://www.cryobank.com/How-It-Works/Donor-Recruitment/ (last visited July 
31, 2010) (touting that their donors are “recruited from world-class universities including . . . 
Stanford University, Harvard University and MIT.”) (internal citations omitted); Conceptual 
Options, What Conceptual Options Provides in Your Search for an Egg Donor, 
http://www.eggdonationcenter.com (last visited July 31, 2010) (“Our program provides a 
comprehensive list of . . . egg donors that possess most physical or mental characteristics 
desired by a recipient family. . . These egg donors possess characteristics of high intelligence 
that is reflected by outstanding scholastic achievement, and/or high test scores on 
standardized and/or graduate school entrance exams . . . Our egg donors must be educated, 
intelligent and between the ages of 20 and 29.”). 
 67. California Cryobank, Inc., Current Prices as of January 2010, http://www.cryo 
bank.com/Services/Pricing/ (last visited July 31, 2010) (listing additional services and fees 
such as a facial features report, donor baby photo, and donor audio interview). 
 68. Donor Gametes, supra note 41, at 114. 
 69. Id. 
 70. Id. 
 71. Id. 
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the wife was never told that her husband was not the biological father of the 
child.72 
Although artificial insemination in humans was possible in the early 
twentieth century, it was not necessarily socially acceptable because women 
undergoing the procedure were often considered to have committed 
adultery.73  In addition, children conceived through donor insemination were 
considered illegitimate.74  It wasn’t until the 1960s that the procedure 
became more acceptable, reflected by the states of Georgia and California 
confirming the legitimacy of donor-conceived children.75  Finally, in 1973, 
the passage of the Uniform Parentage Act assured that a husband who 
consented to his wife’s artificial insemination procedure would be 
considered the natural father of the child.76  Since the process, no longer 
considered a social taboo, has been facilitated in recent decades by the 
cryopreservation of sperm, it has become increasingly popular.  
Conservative estimates show that “as of 1996, more than 260,000 human 
births have been achieved through artificial insemination with cryopreserved 
semen.”77 
While sperm donation and artificial insemination have been practiced 
for much of the past century, egg donation is a relatively new procedure.  
The first successful pregnancy resulting from egg donation was reported in 
1984.78  Its use has increased significantly since then.  In 2005, donor eggs 
were used in approximately twelve percent (or 16,161) of all ART cycles, 
resulting in approximately 5,043 births.79 
 
 72. Id. 
 73. G.W. Bartholomew, Legal Implications of Artificial Insemination, 21 MOD. L. REV. 
236, 238, 239 (1958) (citing a 1921 divorce case in which the judge refused to believe that 
the wife had undergone artificial insemination as alleged by the husband.  However, the judge 
ruled that artificial insemination, like sexual intercourse with anyone other than one’s spouse, 
“is adulterous because in the case of the woman, it involves the possibility of introducing into 
the family of the husband a false strain of blood.  Any act on the part of the wife which does 
that would therefore be adulterous.”). 
 74. See Gursky v. Gursky, 242 N.Y.S.2d 406, 411 (N.Y App. Div. 1963) (“[I]t has been 
held that heterologous artificial insemination by a third party donor [which produces a child] 
. . . is not a child born in wedlock and is therefore illegitimate.”); Doornbos v. Doornbos, 139 
N.E.2d. 844 (Ill. App. Ct. 1956). 
 75. See GA. CODE ANN. § 19-7-21 (2004); see also People v. Sorensen, 437 P.2d 495, 
498, 501-02 (Cal. 1968). 
 76. UNIF. PARENTAGE ACT § 5(a), 9b U.L.A. 407 (2001). 
 77. Cryogenic Labs., Inc., The History of Semen Cryopreservation, http://www.cryo 
lab.com/history.shtml (last visited Aug. 21, 2010). 
 78. THIRD PARTY REPRODUCTION, supra note 33, at 4. 
 79. CTRS. FOR DISEASE CONTROL & PREVENTION, 2005 ASSISTED REPRODUCTIVE 
TECHNOLOGY SUCCESS RATES: NATIONAL SUMMARY AND FERTILITY CLINIC REPORTS 56, 56, 59 
(2007) [hereinafter ART SUCCESS RATES], available at http://www.cdc.gov/ART/ART2005/508 
PDF/2005ART508.pdf. 
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B. A Culture of Secrecy 
Since Dr. Pancoast first inseminated his patient without her knowledge, 
secrecy and anonymity have been an industry norm.80  The gamete donor is 
regarded more as a producer of goods than a person; the offspring, a 
product.81  One physician wrote “donor semen should then be regarded as 
‘material’ from an anonymous testis, the donor being actually a 
‘nonperson.’”82  Since donors have traditionally favored anonymity, as have 
recipient individuals or couples, many clinics encourage and some require 
that donors remain anonymous.83  As a result of a policy of secrecy, few 
banks maintain any donor records84 and many even destroy donor records 
once the supply has been exhausted.85 
In recent years, more and more donor-conceived children are 
expressing a vocal opposition to donor anonymity.86  Since ART clinics either 
refuse to divulge any donor information or have no records at all, voluntary 
registries, such as the Donor-Sibling Registry, have formed to link offspring 
to their donors and/or half-siblings.87  The registry is purely voluntary and 
matches individuals via use of the donor number assigned by each sperm 
bank or clinic.88 
The first legislative push to allow children access to their donors’ 
identities occurred in 1984 in Sweden.89  Since then, anonymity for gamete 
donors has been abolished in Austria, Switzerland, the United Kingdom, 
Norway, the Netherlands, New Zealand, and parts of Australia.90  The loss 
of anonymity has resulted in a dramatic drop in the number of gamete 
donors.91  In Britain, clinics that previously had an excess of donated 
specimens must now make concerted efforts to recruit enough donors to 
 
 80. See generally Donor Gametes, supra note 41, at 114, 116-17. 
 81. See generally BRENDA ALMOND, MATTERS OF LIFE AND DEATH 142 (1998). 
 82. Marek Glezerman, Two Hundred and Seventy Cases of Artificial Donor Insemination: 
Management and Results, 35 FERTILITY & STERILITY 180, 185 (1981). 
 83. See, e.g., California Cryobank, Inc., About Your Confidentiality and Anonymity, 
https://www.spermbank.com/newdonors/index.cfm?ID=5 (last visited Aug. 21, 2010). 
 84. D. Meirow & J.G. Schenker, The Current Status of Sperm Donation in Assisted 
Reproduction Technology: Ethical and Legal Considerations, 14 J. ASSISTED REPROD. & 
GENETICS 133, 137 (1997). 
 85. Kotler, supra note 15, at 42. 
 86. See Amy Harmon, Hello, I’m Your Sister. Our Father Is Donor 150. N.Y. TIMES, Nov. 
20, 2005, at 1, 34. 
 87. Id.; The Donor Sibling Registry, Home Page, http://www.donorsiblingregistry.com (last 
visited Aug. 21, 2010). 
 88. Id. 
 89. See Donor Gametes, supra note 41, at 115. 
 90. Id. 
 91. BioCentre, supra note 36. 
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meet patient demand.92  Some clinics are resorting to imported sperm, 
mostly from Scandinavia where anonymity is still guaranteed.93 
“On the other hand, in countries such as Sweden, New Zealand, and 
Australia, different types of donors are coming forward [who] tend to be 
older, in ongoing partnerships and have children.”94  Ken Daniels, an 
adjunct professor at the University of Canterbury in New Zealand and a 
scholar on the creation of families through artificial insemination, argues 
that a culture of openness and information sharing should bring new donors 
to the fore; donors whose primary motivation is altruistic rather than self-
serving.95  They would be “donors” in the true sense of the word.96 
II.  CURRENT FEDERAL, STATE, AND PRIVATE REGULATION OF GAMETE DONATION 
FOR ASSISTED REPRODUCTION 
In Reproduction and Responsibility, a 2004 report about the regulation 
of ART, the President’s Council on Bioethics concluded that “there is no 
uniform, comprehensive, and enforceable system of . . . monitoring, or 
oversight for the biotechnologies affecting human reproduction. . . [or] how 
they affect the well-being of the children conceived with their aid.”97  
Although some federal and state regulations exist, they are piecemeal 
regulations that do not provide comprehensive rules.98  Despite attempts at 
self-regulation, compliance with the standards set forth by industry leaders is 
“purely voluntary.”99 
A. Federal Regulation 
The federal government did not take action to regulate ART until 1992 
in the form of The Fertility Clinic Success Rate and Certification Act (“the 
Act”).100  Passage of the Act was in response to grossly exaggerated and 
misleading success rates advertised by various fertility clinics to lure 
 
 92. Denise Grady, Shortage of Sperm Donors in Britain Prompts Calls for Change, N.Y. 
TIMES INT’L, Nov. 12, 2008, at A10. 
 93. Id. 
 94. Donor Gametes, supra note 41, at 119. 
 95. Id. at 118, 119. 
 96. Id. at 119. 
 97. THE PRESIDENT’S COUNCIL ON BIOETHICS, REPRODUCTION AND RESPONSIBILITY: THE 
REGULATION OF NEW BIOTECHNOLOGIES xvi, xliii (2004) [hereinafter REPRODUCTION AND 
RESPONSIBILITY]. 
 98. See Pino D’Orazio, Half of the Family Tree: A Call for Access to a Full Genetic 
History for Children Born by Artificial Insemination, 2 J. HEALTH & BIOMEDICAL L. 249, 256 
(2006) (arguing that current regulation of the artificial insemination procedure is inadequate); 
see also Guiding Regulatory Reform in Reproduction and Genetics, 120 HARV. L. REV. 574, 
578 (2006) (stating that the current regulation of the ART industry may not be sufficient to 
“resolve the dilemmas” of the future). 
 99. See REPRODUCTION AND RESPONSIBILITY, supra note 97, at xliii. 
 100. See JUDITH DAAR, REPRODUCTIVE TECHNOLOGIES AND THE LAW 687 (2006). 
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customers.101  To date, the Act continues to be the only federal law that 
directly regulates ART.102 
The Act serves two purposes: “(1) to provide consumers with reliable 
and useful information about the efficacy of ART services offered by fertility 
clinics, and (2) to provide states with a model certification process for 
embryo laboratories.”103  First, to ensure that consumers have access to 
accurate data, all ART programs and clinics must provide success rates 
annually to the Society for Assisted Reproductive Technology (“SART”).104  
These rates include information such as the number of pregnancies and live 
births achieved, the types of ART used, and any diagnosed birth defects in 
live-born or still-born infants.105 
To meet the requirements of the Act, a clinic or program must merely 
report its data to SART.106  There are no minimum standards.107  In the year 
2000, 384 of the nation’s 421 ART clinics complied with the reporting 
requirements of the Act.108  For those clinics that fail to report data results, 
the only consequence is being labeled as “nonreporting” in the annual CDC 
report.109  No other penalty is imposed.110 
The second half of the Act provides a model certification process for 
states to increase and maintain quality in embryo labs.111  The Act 
recommends monitoring factors such as record keeping, performance of 
procedures, and quality of personnel, as well as overall quality control.112  
To maintain certification, labs are required to comply with standards 
established by the College of American Pathologists in conjunction with the 
American Society of Reproductive Medicine.113  If the labs fail to comply with 
the standards, states have the authority to remove certification.114 
State participation in the model certification program is purely 
voluntary.115  However, no state has adopted the program.116  One reason 
 
 101. Id. at 687-68. 
 102. See REPRODUCTION AND RESPONSIBILITY, supra note 97, at 47. 
 103. Id. 
 104. Id. at 48. SART is under contract with the U.S. Centers for Disease Control (CDC) to 
implement the Act.  Id. 
 105. Id. 
 106. Id. 
 107. See REPRODUCTION AND RESPONSIBILITY, supra note 97, at 48. 
 108. Id. at 49. 
 109. Id. at 48. 
 110. Id. 
 111. Id. at 50. 
 112. See REPRODUCTION AND RESPONSIBILITY, supra note 97, at 50. 
 113. Id. at 73. 
 114. Id. at 51. 
 115. Id. 
 116. Id. at 50. 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
2010] WHO’S GUARDING THE HENHOUSE 409 
the program has not been adopted could be that it does not allow the states 
to establish “any regulation, standard or requirement which has the effect of 
exercising supervision or control over the practice of medicine in assisted 
reproductive technologies.”117  In addition, clinic participation is purely 
voluntary.118  Therefore, “even if a state were to adopt the program, there is 
no requirement that laboratories apply for certification.”119 
Although the Act provides a variety of information to prospective ART 
patients, it only defines ART services as those that “include the handling 
of . . . oocytes or embryos.”120  Therefore, sperm donation and artificial 
insemination programs are exempt from the requirement.121  As such, they 
essentially operate all aspects of their programs independent of any direct 
federal oversight whatsoever. 
Since ART clinics deal with biological products, they are also subject to 
the oversight of the U.S. Food and Drug Administration (“FDA”) under 
Section 351 of the Public Health Services Act (“PHSA”), outlined in section 
1271 of chapter twenty-one of the Code of Federal Regulations.122  
Pursuant to the PHSA, since 2005 the FDA has required that businesses 
dealing with human cells, tissues, and cellular and tissue-based products 
(“HCT/P’s”), including semen and ova: (1) register with the FDA and list all 
HCT/P’s under the establishment’s control and (2) screen and test donors 
for communicable diseases such as HIV, Hepatitis B and C, and (in the case 
of reproductive tissue) sexually transmitted diseases.123  However, the FDA 
requires that only anonymous sperm donors be screened for communicable 
diseases; no such screening is required for known donors.124  In that case, it 
is up to the patient’s discretion or the individual clinic’s policy to determine if 
testing is warranted.125 
Although Section 1271 of the Code establishes some requirements for 
sperm and egg banks, they are exempt from many of the requirements with 
 
 117. See REPRODUCTION AND RESPONSIBILITY, supra note 97, at 51; 42 U.S.C. § 263a-
2(i)(1) (2006). 
 118. See REPRODUCTION AND RESPONSIBILITY, supra note 97, at 51. 
 119. Id. 
 120. Id. at 47. 
 121. See generally id. 
 122. 21 C.F.R. § 1271 (2007); see also REPRODUCTION AND RESPONSIBILITY, supra note 97, 
at 55. 
 123. 21 C.F.R. § 1271.1 (2007); 21 C.F.R. § 1271.75 (2007); see also U.S. FOOD & 
DRUG ADMIN., DIVISION OF INSPECTIONS & SURVEILLANCE, COMPLIANCE PROGRAM GUIDANCE 
MANUAL: INSPECTION OF HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS 
(HCT/PS) 7341.002 3 (2005) [hereinafter FDA GUIDANCE MANUAL]. 
 124. THIRD PARTY REPRODUCTION, supra note 33, at 9. 
 125. See id. at 10. 
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which other tissue banks must comply.126  Most establishments dealing with 
HCT/P’s must implement a tracking system to “facilitate the investigation of 
actual or suspected transmission of communicable disease and take 
appropriate and timely corrective action.”127  The system must allow tracking 
of donor to recipient and recipient to donor.128  In addition, the tracking 
system must ensure that each HCT/P has an anonymous tracking code, 
excluding any information that may reveal the donor’s identity.129  This 
system ensures that, in the event of a contaminated HCT/P, all relevant 
parties may be notified to discontinue use of the tissue, recall the 
contaminated tissue, and initiate appropriate treatment for recipients while 
maintaining donor anonymity.130 
In addition to the tracking system, establishments dealing with HCT/P’s 
(with the exception of those dealing with reproductive tissue) “must 
investigate any adverse reaction involving a communicable disease related 
to an HCT/P” and then report such adverse reaction to the FDA “if it: (1) [i]s 
fatal; (2) [i]s life-threatening; (3) [r]esults in permanent impairment of a body 
function or permanent damage to a body structure; or (iv) [n]ecessitates 
medical or surgical intervention, including hospitalization.”131  To facilitate 
reporting of adverse events, the FDA runs Medwatch, an electronic reporting 
program.132  Its interactive website allows access not only to mandatory 
reporters, such as those dealing with HCT/Ps, but also to health 
professionals and consumers.133  Therefore, those who may be most 
severely impacted by adverse events (i.e., tissue recipients) have the 
opportunity to report adverse experiences directly to the FDA. 
Unlike the Act, which has minimal enforcement powers, the FDA has 
authority to conduct inspections to determine compliance.134  In the event of 
noncompliance, the offending organization is subject to licensure 
revocation, recall or seizure of previously approved products (e.g., a 
defective batch), or criminal prosecution.135  However, according to the 
 
 126. FDA GUIDANCE MANUAL, supra note 123, at 41 (listing exemptions for reproductive 
tissue). 
 127. 21 C.F.R. § 1271.290(a) (2007). 
 128. 21 C.F.R. § 1271.290(b) (2007). 
 129. 21 C.F.R. § 1271.290(c) (2007). 
 130. 21 C.F.R. § 1271.290(e) (2007). 
 131. 21 C.F.R. § 1271.350(a) (2007). 
 132. U.S. Food & Drug Admin., MedWatch: The FDA Safety Information and Adverse 
Event Reporting Program, http://www.fda.gov/medwatch/default.htm (last visited Aug. 21, 
2010). 
 133. See U.S. Food & Drug Admin., MedWatch: Reporting Serious Problems to FDA, 
http://www.fda.gov/safety/medwatch/howtoreport/default.htm (last visited Aug. 21, 2010). 
 134. REPRODUCTION AND RESPONSIBILITY, supra note 97, at 59. 
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Office of the Inspector General of the Department of Health and Human 
Services, inspection of tissue banks is inconsistent and, in some cases, 
nonexistent.136  In addition, the inspections focus solely on preventing the 
transmission of communicable disease and the reinforcement mechanisms 
are weak: the FDA may serve a written order that the HCT/P be recalled or 
destroyed, order that the establishment cease manufacture until compliance 
is achieved, or itself seize and destroy the HCT/P.137  Once again, the 
regulation exempts reproductive tissue: the FDA will neither destroy such 
tissue, nor will it issue an order to destroy it.138 
In general, federal oversight is minimal with weak enforcement 
mechanisms.139  In addition, the protections provided to patients and 
potential offspring are weak: they focus on data collection and prevention of 
communicable disease.140  However, no genetic testing of gamete donors or 
recipients is required and no long-term tracking system is in place to 
monitor and report adverse events, such as genetic disorders.141  Therefore, 
if a latent health issue becomes evident in the donor or offspring, there is no 
system in place to inform the parties involved or prevent the continued use 
of the affected gametes. 
B. State Regulation 
Since the federal government provides little oversight of ART, some 
states provide additional regulation through direct legislation.142  However, 
most of the legislation targets single issues related to ART rather than overall 
 
 136. DEP’T OF HEALTH & HUM. SERVS., OFF. OF INSPECTOR GEN., OVERSIGHT OF TISSUE 
BANKING 7 (2001).  The report stated that only thirty-six out of a 154 tissue bank sample pool 
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conducted, according to the FDA website. U.S. Food and Drug Administration, Inspections 
Performed in Fiscal Years 1998 - 2009, http://www.fda.gov/BiologicsBloodVaccines/ 
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 137. 21 C.F.R. § 1271.440(a) (2007). 
 138. 21 C.F.R. § 1271.440(f) (2007). 
 139. See generally 21 C.F.R. § 1271 (2007); REPRODUCTION AND RESPONSIBILITY, supra 
note 97, at xliii. 
 140. See 21 C.F.R. § 1271.1(a) (2007). 
 141. See REPRODUCTION AND RESPONSIBILITY, supra note 97, at xliv; Judith F. Daar & Robert 
G. Brzyski, Genetic Screening of Sperm and Oocyte Donors: Ethical and Policy Implications, 
302 JAMA 1702, 1703 (2009). 
 142. Lynn D. Wardle, Global Perspective on Procreation and Parentage by Assisted 
Reproduction, CAP. U. L. REV. 413, 464 app. II (2006) (provides a table for an overview of all 
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industry standards: mandated insurance benefits, parental rights and 
obligations, regulation of research, and surrogacy to name a few.143 
Of all the states that have created such legislation, New Hampshire 
most widely regulates ART’s effect on the health and safety of patients and 
their offspring.144  Under its legislation, all patients, gamete donors, and 
gestational carriers must “undergo a medical evaluation and be deemed 
‘medically acceptable’ before treatment can be administered.”  In addition, 
“parents enlisting a gestational carrier” are required to “undergo genetic 
counseling, if the surrogate is [thirty-five] or older.”145  However, other than 
those requirements, clinics have free rein regarding all aspects of their 
practice.  In addition, even if one state elects to regulate the ART industry, 
clinics are free to move to other states to avoid such requirements. 
In addition to direct legislation, states may regulate through licensing of 
health care providers and facilities146 and through civil claims.147  Through 
licensure requirements, physicians who deviate from a quality standard of 
care may be subject to discipline as determined by their state licensure 
boards.148  Of course, proving the standard of care in such a laissez-faire 
industry may be difficult.149  Through licensure of facilities, states can ensure 
minimal compliance with safety regulations.150  However, currently New 
York and California are the only states to inspect sperm and egg banks prior 
to issuing a license.151  Therefore, state oversight may be questionable. 
Like the federal regulation, state regulation does not create or reinforce 
a system to ensure the future health of donor offspring.  For example, under 
New Hampshire regulations, all parties involved in ART must be deemed 
medically acceptable to participate; once they pass the initial medical 
evaluation, no additional medical testing or reporting is required.152  The 
statute does not define “medical acceptability.”153  Therefore, it is unclear 
what present health concerns are addressed under the law and apparent 
that future health concerns are not addressed at all. 
 
 143. See DAAR, supra note 100, at 691. 
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Finally, the ART industry may be regulated through civil action.154  
Dissatisfied patients may seek monetary damages through claims of 
negligence, misrepresentation, fraud, or lack of informed consent.155  
Although issues regarding ART practices are litigated, the effect of such 
litigation on overall quality of care is debatable.156 
In Johnson v. California Cryobank,157 a couple sued a sperm bank for 
failure to disclose that the donor had a family history of kidney disease.158  
The family alleged that the sperm bank knew of the donor’s history, which 
the sperm bank vehemently denied.159  Due to the seriousness of the 
disease, the court determined that the state interest outweighed the donor’s 
right to privacy and ordered the sperm bank to turn over the donor’s 
medical records and present the donor for depositions, while protecting his 
identity as much as possible.160  However, the court ultimately determined 
no liability on the part of the sperm bank or its physicians because, although 
they were improper in approving a donor at risk for kidney disease, they did 
not cause the inherited disorder.161 
C. Private Regulation 
Many tissue banks seek accreditation through a variety of non-profit 
agencies such as the American Association of Tissue Banks (“AATB”), the 
College of American Pathologists (“CAP”), American Society for 
Reproductive Medicine (“ASRM”), Reproductive Laboratory Accreditation 
Program, the Joint Commission on Accreditation of Healthcare 
Organizations (“JCAHO”), or the New York State Tissue Bank Program 
(“NYSTB”).162  While they may impose stricter standards than the FDA, 
accreditation is, once again, generally voluntary.163  In addition to 
accreditation, the ART industry in the U.S. is regulated primarily by voluntary 
guidelines issued by SART.164  To promote consistency of practice, the 
guidelines incorporate information and recommendations from 
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organizations including the CDC, FDA, and AATB.165  In addition to the 
standard testing for communicable disease required by the FDA, the ASRM 
recommends a psychological consultation, physical examination, and a 
minimum genetic screening of donors.166  Once screening and test results 
are complete, the ASRM recommends that a permanent record be kept.167 
Although the guidelines may exceed requirements of federal and state 
regulations, they are mere recommendations without any enforcement 
mechanism to induce compliance.168  Therefore, 
the current system of self-regulation does not effectively curtail harmful and 
unethical ART practices . . . . [E]xisting enforcement mechanisms are 
ineffective.  On-site validations of laboratories only occur every three years, 
which is too infrequent to assess practices in such a quickly evolving field.  
Further, compliance with the standards is voluntary and not every program is 
a member of ASRM.  The penalty for noncompliance is removal from group 
membership, but violators are still free to offer services to willing parents.  
As a result, non-reporters can still build a lucrative fertility practice without 
any effective oversight.169 
In light of the dearth of accountability in the field, there is increased 
demand for more stringent oversight of the industry because having the fox 
guard the henhouse may not be the wisest decision.170 
III.  HEALTH CONCERNS RELATED TO UNREGULATED DONOR ASSISTED 
REPRODUCTION 
According to the Code of Medical Ethics of the American Medical 
Association, “a physician shall . . . regard responsibility to the patient as 
paramount.”171  By playing a major role in the creation of offspring through 
ART, surely the physician has a duty to take reasonable precautions to 
ensure the health of those donor-conceived offspring. 
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A. Health History 
In 2003, the federal government believed so strongly in the health 
benefits of knowing family history that it supported the collaboration of the 
Surgeon General and Department of Health and Human Services in 
establishing the Family History Initiative “to encourage all American families 
to learn more about their family health history.”172  The Family History 
Initiative states on its website that: 
Knowing your family history can help your doctor predict your risk of 
developing diseases like heart disease, stroke, diabetes, and cancer . . . . 
Using family history helps identify if you or others in your family . . . may be 
at increased risk for disease.  A family health portrait given to your primary 
care provider helps your provider consider both your genes and these other 
shared risk factors influencing your health.173 
Even with a predisposition to a certain disease or disorder, individuals 
can change behaviors that affect their health, such as smoking, inactivity, 
and poor eating habits.174  By making lifestyle changes, the risk of disease 
can be reduced even if it is genetic.175  In addition to making changes in 
diet and exercise, at-risk individuals can 
participate in screening tests, such as mammogram and colorectal cancer 
screening, for early detection of disease.  People who have a family health 
history of a chronic disease may benefit the most from screening tests that 
look for risk factors or early signs of disease.  Finding a disease early, 
before symptoms appear, lends to a better prognosis and better health in 
the long run.176 
Of course, individuals who don’t know their health history, such as 
adoptees or donor-conceived children, are at a disadvantage when it comes 
to predicting their risk of developing a particular disease.  To address this 
issue, the Initiative’s website provides helpful tips for adoptees to discover 
their health history including using the Child Welfare Information Gateway 
to gain access to birth parents.177  Unfortunately, such resources are 
unavailable to donor-conceived children. 
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Although they may have a copy of their health history provided by the 
ART clinic, there is no guarantee that the data is correct.  First, gamete 
donors may be hesitant to reveal any negative health history for fear of 
being excluded from the program (and, therefore, excluded from the 
income).178  Second, most gamete donors are young—in their early to mid-
twenties—and either do not know their family history or may be susceptible 
to disorders that surface only later in life.179  Since clinics generally do not 
conduct long-term follow-up on donor health, latent disorders aren’t 
included in the history.180 
B. Consanguinity 
Another major health concern surrounding the donor-gamete industry is 
consanguinity, or “accidental incest.”  Due to the potentially large numbers 
of progeny resulting from unregulated donation as well as the anonymity of 
the donors, there is legitimate concern over whether half-siblings could 
unknowingly meet and develop a romantic relationship.  The number of 
children born through ART has increased annually.181  According to the 
CDC, 20,840 infants were born through ART in 1996; that number 
increased to 52,041 in 2005.182  Since the reporting of births using donor 
conception is voluntary, estimates vary widely.  A survey of Artificial 
Insemination Practice conducted by the U.S. Office of Technology 
Assessment estimated that 30,000 births resulted from donor insemination 
in 1986-1987.183  Numbers may be as low as 4,000-5,000 children born 
each year through donor insemination or as high as 40,000.184  
Unfortunately, since no tracking system of donor gametes exists, it is unclear 
how many offspring each individual donor has produced.185  However, the 
creator of the Donor Sibling Registry, Wendy Kramer, confirmed that one 
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group of donor-conceived children from a single donor numbers 110, not 
counting the current pregnancies.186 
Accidental incest was a concern even in the early days of donor 
insemination.187  A 1957 medical text states 
it is by no means an imaginary danger, especially if such a thing takes place 
in a small town, that 25 years later a young man and girl with a common 
father may marry . . . . This danger has been envisaged by a clinic in 
England and an attempt has been made to ward it off by forbidding a donor 
to offer his services more than 100 times.  But what is to prevent this donor 
from going to some other clinic or doctor and starting all over again?188 
The text goes on to predict 
in the foreseeable future, [donor insemination] will be legally sanctioned in 
many of the States in the U.S.A., for which reason there should be no further 
delay in: (a) Setting up semen banks for the supply of carefully checked 
semen.  (b) Keeping records, both at the bank and at the Registry of Births, 
of the name of the biological father and the name of the couple having the 
custody of the donor-child; (c) Taking the necessary steps to prevent the 
couple and the donor from knowing each other’s identity despite these 
inroads made upon anonymity.189 
Unfortunately, other than the creation of banks for donated gametes, 
none of the other recommended precautions have been implemented.  
However, in response to such concerns, the ASRM recommends that use of 
a specific donor’s sperm be limited to twenty-five live births per population 
area of 800,000.190  Once again, these guidelines are strictly voluntary 
and, even if followed, do not prevent a donor from spreading his donations 
among several clinics, thereby skirting the limitation.191 
Although concerns regarding accidental incest may seem far-fetched, 
they were realized for a newlywed couple in Britain who discovered that they 
were twins separated at birth.192  “It was appalling for this couple to discover 
they were married to a close relative.”193  Upon discovering their familial 
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relationship, the couple immediately requested an annulment.194  Since no 
children were produced, the only harm suffered was the emotional pain of 
losing a loved one.195  Similarly, Lori Andrews recounts in her book, The 
Clone Age, two accounts of infertility doctors halting marriages between 
“individuals they knew to have been fathered by the same donor.”196 
If half-siblings are raised in close proximity to one another, it is not 
outside the realm of possibility that they may meet and interact.  And, 
according to Pam Hodgkins, chief executive officer of Adults Affected by 
Adoption, such siblings may be attracted to one another because people 
are “naturally drawn to [those] who are quite similar to [them]selves.”197 
Since adopted children are generally more knowledgeable about their 
birth history and there has been a greater legislative push to open adoption 
records, consanguineous relationships may be less likely for them in the 
future.198  In contrast, children conceived via donor gametes may not be 
told of the circumstances surrounding their conception due to secrecy and, 
even with that knowledge, may find it impossible to discover their genetic 
history due to a lack records.199  Therefore, concerns about consanguinity 
remain a distinct possibility. 
C. Adoption Model: Current Rights of Adoptees Regarding Health History 
and Genetic Information 
Like donor-conceived offspring, adopted children have traditionally been 
excluded from knowing the identity of their biological parents.200  Like 
donor-conceived offspring, many seek their biological parents without 
success due to long-standing protocols that aim to preserve anonymity.201  
In recent years, there has been a push to allow adoptees’ access to their 
original birth records, including the birth parents’ identifying information.202  
A report published by the Evan B. Donaldson Adoption Institute in 2007 
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analyzed the outcomes of such laws.203  Despite fears that some adopted 
children might stalk their birth parents or exhibit intrusive behavior, no such 
evidence emerged.204  In fact, 
[f]or many adopted persons, the desire to obtain their records is entirely 
separate from any desire to search for their birthmothers or other relatives; 
they simply believe—as a human and civil right—that they are entitled to the 
same basic information about themselves that people raised in their birth 
families receive as a matter of course.  Indeed, many who do get their birth 
certificates or other documents never search, while others successfully 
search (a growing phenomenon because of the internet) without any of their 
documents.205 
V.  RECOMMENDED POLICIES TO IMPROVE ACCESS TO GENETIC HISTORY OF 
DONOR OFFSPRING AND THEIR POTENTIAL CHILDREN 
Since states and the ART industry itself have provided little oversight of 
donor-assisted reproduction,206 the process has become a lucrative business 
that prioritizes profits over the well-being of its participants.207  The federal 
government must intervene and set some minimal national standards to 
assure the health and well-being of donor-conceived children.  To prevent 
clinics, donors, or recipients from hopping state-to-state in search of the 
most favorable regulations, a national standard is preferable to piecemeal 
state legislation. 
Although many donor-conceived offspring support non-anonymous 
gamete donation,208 it is not addressed in the following recommendations.  
As a practical matter, change is more likely to be implemented in a timely 
fashion if controversial issues are excluded.  Since non-anonymous donation 
continues to be a topic of contentious debate,209 it is beyond the scope of 
this paper. 
A. Required Accreditation of All ART Facilities 
Legislation should be enacted to require that all facilities implementing 
ART be accredited by a national organization, such as the ASRM.  Absent 
such accreditation, those facilities should receive no federal funding tied to 
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research or reimbursement.  To earn such accreditation, facilities should be 
required to comply with all current ASRM guidelines, including: 
(i) the Minimum Genetic Screening for Gamete Donors which would 
exclude potential donors with major mendelian disorders, major 
malformations of complex cause, familial disease with any genetic 
component, or any abnormality that “may result in chromosomally 
unbalanced gametes.”210  In addition, the Minimum Genetic Screening 
recommends genetic testing for any member of a high-risk group “to 
determine carrier status.”211 
(ii) the Limitation on donor use restricting a single donor to no more 
than 25 births in a population of 800,000.212 
Implementation of these precautions would reduce the chance of donor 
offspring inheriting genetic disorders or being exposed to inadvertent 
consanguinity and its negative health consequences.213 
Since implementation of this recommendation may be costly, expenses 
could be offset by accreditation fees and fines imposed for violations of 
these guidelines.214  In addition to the fines, continued noncompliance with 
the guidelines should result in revocation of accreditation and withdrawal of 
federal funding.215 
B. Expand FDA Oversight 
As previously discussed, the FDA already has the authority to oversee 
ART clinics under Section 351 of the Public Health Services Act.216  
However, its authority is limited and requires neither tracking of reproductive 
material nor reports of adverse reactions.217  In addition, there are minimal 
consequences for noncompliance with the regulations.218  The following are 
recommended to strengthen the FDA’s oversight of ART clinics: 
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(i) Require Tracking of Donor Gametes under 21 C.F.R. § 1271.290.219 
The system should allow, as outlined in the regulation, tracking of 
gametes from the donor to the recipient and the recipient to the donor 
through implementation of a code system to allow continued donor 
anonymity.220  Such a tracking system would facilitate notification of 
recipient families of potential genetic disorders reported by other families 
who received gametes from the same donor.  Timely notification would 
provide the families with the power to initiate genetic testing for detection of 
the disease, intervene as early as possible with lifestyle modifications to 
prevent or delay onset of the affliction, participate in regular screenings for 
early detection, or begin treatment.  In addition, a tracking system would 
facilitate recall of unused gametes that may carry a genetic disorder. 
(ii) Require Clinics Dealing with Reproductive Tissue to Comply with 
Reporting Guidelines and Expand Reporting of Adverse Reactions to Include 
Genetic Disorders under 21 C.F.R. § 1271.350.221 
Requiring them to comply with reporting guidelines that already exist 
under section 1271.350 could enforce the accountability of sperm and egg 
banks to recipient families.222  In addition, the regulations should be 
expanded to require that clinics report not only adverse reactions involving 
communicable diseases, but also those involving genetic disorders.  The 
current wording of the regulation as it applies to communicable disease 
could also apply to genetic disorders.223  Therefore, clinics would be 
required to report to the FDA an adverse reaction involving a genetic 
disease if it: (1) is fatal, (2) is life-threatening, (3) results in permanent 
impairment of a body function or permanent damage to a body structure; or 
(4) necessitates medical or surgical intervention, including hospitalization.224 
Since a mandatory reporting system of adverse reactions is currently in 
effect through MedWatch, implementation of the additional reporting 
requirements would place a minimal burden on the system.225  In addition, 
compliance with reporting requirements would be reinforced through 
MedWatch’s system of allowing not only clinics to report but also health 
care workers and families.226  Having those with the most at stake take part 
in the reporting process would likely increase the incidence of reporting and 
would also provide the FDA with information regarding adverse reactions 
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that may not have been independently reported by the clinics, thereby 
increasing clinic accountability. 
(iii) Implement Fines as an Enforcement Mechanism. 
In the past, the FDA has not enforced regulation of the tissue industry 
with fines, primarily because most of the organizations involved are 
traditionally not-for-profit.227  However, the FDA has the authority to impose 
fines for noncompliance.228  If clinics are faced with fines that may eat into 
their profit margins, they may be more likely to comply with the regulations 
than if faced with inconsistent inspections. 
C. Creation of Mandatory National Database of Gamete Donors 
The three largest sperm banks in the U.S. advocate for the creation of a 
voluntary registry of gamete donors.229  Unfortunately, no industry-wide 
voluntary registry has been formed.  Therefore, establishment of a 
mandatory national database of gamete donors is essential to allow donor-
conceived offspring anonymous access to their medical and/or genetic 
histories.  Such a registry would address two of the controversial issues 
surrounding donor-assisted conception and could be implemented through 
the authority of the ASRM.  First, if each donor were assigned a unique 
number, clinics could track the number of gamete donations per donor and 
the number of offspring produced, even if the donor elected to use different 
clinics. 
Second, with such a system, donations could be effectively limited by the 
ASRM recommendations.  Without a tracking system, clinics must rely solely 
on their own data.  If a donor elects to donate at more than one clinic, each 
clinic’s data is irrelevant as the total number of offspring would go 
unmonitored.  Pooled into a national database, the data would provide a 
clearer picture of whose gametes were going where. 
D. Mandatory Documentation of Donor-Conception in Birth Record 
Even if a national donor registry is created documenting the health 
history of donors, it is useless unless the donor-conceived child has 
knowledge of the circumstances surrounding his or her conception.  
Although the ASRM encourages parents to disclose genetic heritage to their 
children, some opt to keep the facts surrounding their child’s conception a 
secret, even to the child.  If a child believes he is the biological offspring of 
both his parents, he has no incentive to investigate his true genetic history.  
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Therefore, without a mechanism to inform children of their biological 
parentage, the database would be pointless. 
To ensure that all donor-offspring are informed of their true genetic 
heritage, there should be mandated documentation of donor conception on 
each child’s birth record.  This documentation would not affect the true 
parent from being listed on the birth record; it would merely clarify that the 
child was conceived through the use of donor gametes. 
By providing this information, each donor-conceived child would have 
the opportunity to access the database for an accurate health history and 
any other pertinent information available on the record. 
E. Possible Barriers 
Because a national tracking system would require collaboration of 
hundreds of clinics and individuals, it would likely cost a significant amount 
of money to implement.  The extra time and manpower required to maintain 
records and provide reports would likely increase the cost of already 
expensive ART.  Such cost increases might affect patients’ access to this type 
of care, as insurance typically does not cover most ART procedures and any 
increase could price many patients out of the market. 
In addition, fears regarding loss of anonymity through the tracking 
system may result in a reduction of gamete donations.  If potential donors 
believe their identity could be compromised through the database, they may 
be more reluctant to donate. 
As a result of increased regulation, higher costs, or a reduction in 
gamete donors, recipient couples may opt to travel internationally for their 
reproductive procedures.  Such medical tourism has become popular in 
recent years for those interested in cosmetic surgery, orthopedics, or weight 
loss surgery.230  It is conceivable that couples desperate for a child would 
elect to travel for treatment rather than spend a life’s savings for a 
procedure that would be half the cost abroad or wait months or years on a 
waiting list for donor sperm. 
CONCLUSION 
As the use of ART becomes more common and its technology allows 
more options for creating a family, society must consider the effect on all 
participants involved in the process—and in particular the resultant children.  
Success should not be measured by whether a child was conceived or 
whether the child exhibits the genetic traits selected by the parents.  Rather, 
success should be measured by whether that child has the ability to know his 
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or her genetic heritage and whether that child can develop serious 
relationships without fear of consanguinity. 
Since the ART industry has failed thus far to self-impose regulations to 
ensure the health and well-being of its most innocent patients, it is time for 
the legislature to step forward.  To prevent the spread of hereditary disorders 
and the risk of inadvertent consanguinity, increased regulation of the 
industry must be implemented including required accreditation of ART 
facilities, expanded FDA oversight of ART, creation of a mandatory national 
gamete donor database, and mandatory documentation of donor 
conception in birth records. 
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